Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

ACADSB – 2-Methylbutyryl-CoA Dehydrogenase Deficiency

ACADSB encodes short/branched-chain acyl-CoA dehydrogenase (SBCAD), and biallelic variants cause autosomal recessive 2-methylbutyryl-CoA dehydrogenase deficiency ([MONDO:0012392]). This inborn error of L-isoleucine metabolism presents with variable neurologic features, including athetoid cerebral palsy (HP:0011445) and autism spectrum disorders (HP:0000717).

Inheritance is autosomal recessive. Across two newborn-screening cohorts, 4 affected individuals from 2 Hmong families and 12 non-Hmong probands have been reported with biallelic ACADSB variants, including splice-site and missense alleles ([PMID:12837870], [PMID:20547083]).

Segregation analyses in multiple families demonstrated co-segregation of the IVS3+3A>G (c.303+3A>G) splice mutation with metabolite abnormalities in affected siblings and an asymptomatic carrier mother ([PMID:17883863]).

Functional assays confirm pathogenicity: patient fibroblast enzyme activity is abolished using 2-methylbutyryl-CoA substrate ([PMID:11013134]), minigene splicing assays show exon skipping due to c.303+3A>G ([PMID:16317551]), and bacterial expression of novel missense alleles yields unstable or inactive enzymes.

The clinical spectrum ranges from severe motor delay and cerebral palsy to asymptomatic infancy under dietary management, indicating variable expressivity and incomplete penetrance.

Integration of genetic, segregation, and functional data supports a strong gene–disease relationship. Early detection by tandem mass spectrometry newborn screening enables presymptomatic dietary intervention.

References

  • Pediatrics • 2003 • Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. PMID:12837870
  • Molecular Genetics and Metabolism • 2010 • Characterization of new ACADSB gene sequence mutations and clinical implications in patients with 2-methylbutyrylglycinuria identified by newborn screening. PMID:20547083
  • Journal of Medical Case Reports • 2007 • 2-methylbutyryl-CoA dehydrogenase deficiency associated with autism and mental retardation: a case report. PMID:17883863
  • American Journal of Human Genetics • 2000 • Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA dehydrogenase deficiency: identification of a new enzyme defect… PMID:11013134
  • Human Genetics • 2006 • Short/branched-chain acyl-CoA dehydrogenase deficiency due to an IVS3+3A>G mutation that causes exon skipping. PMID:16317551

Evidence Based Scoring (AI generated)

Gene–Disease Association

Strong

Approximately 16 probands across 12 families with biallelic ACADSB variants and concordant biochemical phenotypes

Genetic Evidence

Strong

17 affected individuals with confirmed biallelic variants in ACADSB across Hmong and non-Hmong cohorts; AR segregation in multiplex families

Functional Evidence

Moderate

Enzyme assays in patient fibroblasts, bacterial expression studies, and splicing assays consistently demonstrate loss of SBCAD function ([PMID:11013134], [PMID:16317551])